Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for Co-occurring Alcohol Dependence and Major Depressive Disorder
NCT02185131Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Sep 2013
- Primary completion
- Jul 2016
- Countries
- 1
01
Overview
A Phase 2 trial of mirtazapine in alcohol use disorder (AUD), major depressive disorder (MDD), sponsored by University of Pittsburgh. Started Sep 2013; status: completed.
02
Drugs
mirtazapine
03
Conditions
alcohol use disorder (AUD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02185131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02185131.